Effects of Vaginal Estrogens on Serum Estradiol Levels in Postmenopausal Breast Cancer Survivors and Women at Risk of Breast Cancer Taking an Aromatase Inhibitor or a Selective Estrogen Receptor Modulator

BACKGROUND: Intravaginal estradiols (VE) have been proposed as safe alternatives to systemic estrogen therapy in breast cancer survivors. PATIENTS AND METHODS: Postmenopausal women with estrogen receptor–positive breast cancer or at high risk for breast cancer (n = 24) who were taking an aromatase i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Wills, Shannon, Ravipati, Anita, Venuturumilli, Padmaja, Kresge, Cynthia, Folkerd, Elizabeth, Dowsett, Mitch, Hayes, Daniel F., Decker, David A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2012
Gaiak:
Health Care Delivery
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3396801/
https://ncbi.nlm.nih.gov/pubmed/22942807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2011.000352
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak